Shanghai Biopharmaleader co.,ltd

If you are going to consult the information about 202189-78-4 from one of the leading 202189-78-4 manufacturers and suppliers in China,Website:://.biopharmaleader.net, Biopharmaleader Co.,Ltd is always at your service.Product InformationCAS NO.202189-78-4 Product NameBilastineSynonymsFormulaC28H37N3O3Molecular Weight463.61Spec / Purity98%minSupply CapacityDetailsBilastine is a second generation antihistamine drug for the treatment of allergic rhinoconjunctivitis and urticaria (hives).It exerts its effect as a selective histamine H1 receptor antagonist, and has a effectiveness similar to cetirizine, fexofenadine and desloratadine. It was developed in Spain by FAES Farma. Bilastine has been effective in the treatment of ocular symptoms and diseases of allergies, including rhinoconjuctivitis. Additionally, bilastine has been shown to improve quality of life, and all nasal and ocular symptoms related to allergic rhinitis.